Notable Labs News

Vascular Biogenics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Oct 10, 2023 08:01 ET

Vascular Biogenics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Oct 4, 2023 16:33 ET

Vascular Biogenics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Oct 2, 2023 17:31 ET

Vascular Biogenics | 424B3: Prospectus

Oct 2, 2023 17:29 ET

Vascular Biogenics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Sep 18, 2023 17:27 ET

Vascular Biogenics | 424B3: Prospectus

Sep 18, 2023 17:21 ET

Vascular Biogenics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Sep 6, 2023 08:17 ET

Vascular Biogenics | EFFECT: Others

Sep 6, 2023 00:15 ET

Vascular Biogenics | 424B3: Prospectus

Sep 5, 2023 18:02 ET

Vascular Biogenics | S-4/A: Registration of securities issued in business combination transactions (Amendment)

Sep 5, 2023 15:52 ET

Vascular Biogenics | S-4/A: Registration of securities issued in business combination transactions (Amendment)

Sep 1, 2023 17:13 ET

Vascular Biogenics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Sep 1, 2023 17:06 ET

Vascular Biogenics | S-4/A: Registration of securities issued in business combination transactions (Amendment)

Aug 23, 2023 17:06 ET

Vascular Biogenics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Aug 14, 2023 08:06 ET

Vascular Biogenics | S-4/A: Registration of securities issued in business combination transactions (Amendment)

Jul 26, 2023 16:06 ET

Vascular Biogenics | S-4/A: Registration of securities issued in business combination transactions (Amendment)

Jun 30, 2023 16:38 ET

Vascular Biogenics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jun 9, 2023 16:31 ET

Vascular Biogenics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

May 17, 2023 16:54 ET

Vascular Biogenics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

May 15, 2023 16:06 ET

Vascular Biogenics | S-4: Registration of securities issued in business combination transactions

May 11, 2023 09:09 ET